Outreach for Patients That Are Newly Eligible for Colorectal Cancer Screening (UPQUAL)
Using Precision Performance Measurement To Conduct Focused Quality Improvement. Sub-study 2
Studieöversikt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Studietyp
Studietyp
Inskrivning (Faktisk)
Inskrivning
Fas
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Illinois
-
Chicago, Illinois, Förenta staterna, 60611
- Northwestern Medical Faculty Foundation General Internal Medicine Clinic
-
-
Deltagandekriterier
Urvalskriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patient of Northwestern Medical Faculty Foundation General Internal Medicine
- Patient has a scheduled appointment with a GIM physician in the next several weeks
- Patient will be 50 years old at the time of this appointment
- Patient is male or female
Exclusion Criteria:
- This is the first time the patient is seen in the NMFF GIM clinic
- There is a prior completion of CRC screening noted in EHR.
- There is a prior order placed for CRC screening in EHR.
- Patient has a history of CRC
- Patient has a diagnosis of ulcerative colitis, inflammatory bowel disease, Crohn's Disease, or documented colectomy.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Antal vapen
Vapen och interventioner
Deltagargrupp / ArmDeltagargrupp / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Inget ingripande: Usual Care
Usual Care.
Participants in this arm will receive Usual care until outcome assessment is performed at 6 months following randomization.
At that time, they will be sent a letter reminding them to obtain the ordered preventative service test, however no further outcomes will be assessed.
Thus, during the course of the study, all participants in this arm will have solely received usual care.
|
|
|
Experimentell: Behavioral: Letter Only
Behavioral: Letter Only Prior to a scheduled upcoming appointment, participants will get a letter signed by their physician that provides brief information about colorectal cancer (CRC) and notes the importance of CRC screening.
|
Prior to a scheduled upcoming appointment, participants will get a letter signed by their physician that provides brief information about colorectal cancer (CRC) and notes the importance of CRC screening.
|
|
Experimentell: Behavioral: Letter and Educational DVD
Behavioral: Letter and Educational DVD Participants will get a letter from their physician that provides brief information about colorectal cancer (CRC) and notes the importance of CRC screening.
It will be accompanied by an educational DVD about the screening.
The participants will receive this prior to a scheduled upcoming appointment with their physician.
|
Participants will get a letter from their physician that provides brief information about colorectal cancer (CRC) and notes the importance of CRC screening.
It will be accompanied by an educational DVD about the screening.
The participants will receive this prior to a scheduled upcoming appointment with their physician.
|
Vad mäter studien?
Primära resultatmått
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Completion of CRC Screening
Tidsram: 6 months from initial contact
|
What would have been reported as this Outcome Measure is the number of participants who completed screening.
We planned to review electronic health records of participants 6 months post randomization to look for either: (1) note in free text MD note documenting receipt of one form of colorectal cancer (CRC) screening during study period or (2)lab results from fecal occult blood test, sigmoidoscopy, or colonoscopy.
Screening completion equaled presence of a lab result or physician note in chart.
No patient charts were reviewed due to low accrual.
|
6 months from initial contact
|
Sekundära resultatmått
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
The Secondary Outcome for the Study is the Time to Screening Completion.
Tidsram: 6 months after randomization
|
This Outcome Measure would have reported the length of time, measured in days, that occurred between the date of randomization and the completed screening date.
We planned to review the electronic health records of participants 6 months post randomization to look for either: (1)note in free text MD note documenting receipt of one form of CRC screening during study period or (2)lab results from fecal occult blood test, sigmoidoscopy, or colonoscopy.
Screening completion equaled presence of a lab result or physician note in chart.
No patient charts were reviewed due to low accrual.
|
6 months after randomization
|
Samarbetspartners och utredare
Sponsor
Sponsor
Samarbetspartners
Samarbetspartners
Utredare
Utredare
- Huvudutredare: Kenzie Cameron, PhD, Northwestern University, Department of General Internal Medicine
Studieavstämningsdatum
Studera stora datum
Studiestart
Studiestart
Primärt slutförande (Faktisk)
Primärt slutförande
Avslutad studie (Faktisk)
Avslutad studie
Studieregistreringsdatum
Först inskickad
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Första postat
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste uppdatering publicerad
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
Andra studie-ID-nummer
- 1R18HS017163-02 (U.S.A. AHRQ-anslag/kontrakt)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .